Location History:
- Osaka, JP (2011)
- Ibaraki, JP (2010 - 2012)
Company Filing History:
Years Active: 2010-2012
Title: **Innovations by Yasuko Mori: Pioneering Gene Transfer Technologies**
Introduction
Yasuko Mori, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of gene transfer technologies. With a portfolio that includes five patents, her work focuses on utilizing viral vectors for therapeutic applications, particularly in immunocompetent cells.
Latest Patents
One of her latest patents is a revolutionary recombinant viral vector for gene transfer into lymphoid cells. This invention details a recombinant herpesvirus, a method for producing it, and a pharmaceutical composition that utilizes this virus. The method employs a bacterial artificial chromosome (BAC) vector sequence, providing a sophisticated approach to gene transfer in lymphoid cells. Another notable patent she holds is for a promoter designed to induce selective and strong expression in immunocompetent cells and blood cells, notably lymphocytes. This invention leverages the discovery that specific promoters from HHV6 and HHV7 lead to targeted gene expression, enhancing the delivery of DNA vaccines.
Career Highlights
Yasuko Mori has held influential positions at notable institutions, including Osaka University and the Research Foundation for Microbial Diseases of Osaka University. Her research has not only advanced the understanding of gene therapy but has also paved the way for innovative treatments in the medical field.
Collaborations
Throughout her career, Mori has collaborated with esteemed colleagues, including Masaya Takemoto and Koichi Yamanishi. These partnerships have enabled her to extend the reach of her research and further enhance the development and application of her inventions.
Conclusion
Yasuko Mori's inventive spirit and dedication to her research make her a prominent figure in the field of gene transfer technologies. Her patents, which focus on the use of recombinant viral vectors and novel promoters, highlight her significant contributions to medical science and showcase her potential to impact future therapeutic developments.